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Abstract
Background: Primary meningococcal arthritis is a rare infectious disease that occurs in less than 3% of
meningococcal infections and is characterized by arthritis without meningitis, fever, rash, or hemodynamic
instability Barahona [Case Rep Orthop 4696014:2017 ]. There are no validated clinical criteria that can be used for
the diagnosis. We present two pediatric cases of atypical presentation of meningococcal disease revealed by
molecular tests.
Case presentation: The clinical presentation of the two children (6- and 9-years-old) was characterized by signs of
arthritis. By Real Time Polymerase Chain Reaction (RT-PCR), we identified N. meningitidis serogroup Y in the joint
fluid in both cases. After specific antimicrobial treatment, the clinical conditions of the two patients quickly
improved during hospitalization. Conclusions. We believe that the incidence of meningococcal arthritis could be
underestimated in those settings where the use of RT-PCR is limited. Clearer data on the incidence of
meningococcal disease would help to design specific treatments and the best possible national vaccine strategies
[Fiji Sci Rep 23:39784, 2016, J Infect 67:385-90, 2013].
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Background
Primary meningococcal arthritis (PMA) is an uncom-
mon form of meningococcal disease presenting as iso-
lated septic arthritis without any other signs of invasive
meningococcal disease (IMD). It is clinically impossible
to differentiate PMA from other types of septic arthritis.
Synovial fluid culture and molecular tests are pivotal the
confirmation of PMA [1–7]. We discuss two PMA cases
diagnosed by Real Time Polymerase Chain Reaction
(RT-PCR) following the admission in our hospital of two
children in January and March 2017, respectively.
Cases presentation
Case 1
A 6-year-old female with Down syndrome presented at
our emergency department with a 24-h history of fever,
left hip joint pain and limping. She had been previously di-
agnosed with compensated mitral valve prolapse, reported
a past episode of pneumonia and underwent adenotonsil-
lectomy for obstructive apnea 3 years earlier. One month
before admission she traveled to Cuba with her family. On
admission, she was febrile with left coxofemoral joint pain
and movement impairment. Blood tests showed increased
white cells count (WCC) with neutrophilia (WCC 23070/
mm3, N 90%) and a raised C reactive protein (CRP 10mg/
dl, normal < 0.29mg/dl). A left coxofemoral ultrasound
documented a 10mm intra-articular fluid effusion.
Case 2
A 9-year-old male attended the emergency department
with a 3-days history of right ankle joint pain
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non-responding to non-steroidal anti-inflammatory drugs,
limited joint movement and apyrexial. The child had been
adopted from Hungary the year before and was diagnosed
and treated for Toxocariasis at the baseline health screening
as an adopted child. There was no recent history of close
contact with other children and no history of respiratory or
urinary tract infections.
Blood tests showed increased WCC with neutrophilia
(WCC 13700/mm3, 70% N), C reactive protein (CRP 11
mg/dl, normal < 0.29 mg/dl), and erythrocyte sedimenta-
tion rate (ESR 64mm/h, normal < 15mm/h). A right hip
X-ray was normal, whereas right hip ultrasound showed
an 11-mm intra-articular effusion and swelling of the
right synovial capsule. He did not present any other lo-
cation of arthritis or arthralgia.
Case 1 and case 2: Diagnosis, treatment, and outcome
Both patients were admitted to our pediatric ward to be
started on empirical antimicrobial treatment with intra-
venous ceftriaxone and oxacillin for suspected septic
arthritis, as recommended in the literature [8]. RT-PCR
was performed on the synovial fluid on day 3 of anti-
biotic therapy: ctrA gene and specific primers and probes
for A (sacB gene) and B, C, W,Y serogroups (siaD B,
siaD C, siaD W and Y, respectively) were used for the
detection of N.meningitidis as we have previously de-
scribed [9]. The test resulted positive for N. meningitidis
serogroup Y (NmY). Multilocus sequence typing (MLST)
on synovial fluid revealed the presence of the finetype Y
P1.5–2, 10–2: F2–13: ST-23 (cc23) in both samples. Ac-
cording to local IMD treatment guidelines, antibiotic ther-
apy was switched to penicillin G and intravenous
ceftriaxone was continued while waiting for culture con-
firmation and MIC (minimal inhibitory concentration)
value for penicillin; oxacillin was stopped and prophylaxis
for contacts was started [8]. RT-PCR test for N. meningiti-
dis in blood and hemoculture (after 24 h of antimicrobial
therapy with ceftriaxone and oxacillin) and a synovial fluid
culture test (after 48 h of antimicrobial therapy) were nega-
tive in both cases. No bone involvement was detected with
a coxofemoral joint MRI performed in either case (Fig. 1).
Our patients’ clinical conditions quickly improved during
hospitalization. Intravenous antimicrobial therapy was con-
tinued for 15 days and was subsequently switched to oral
treatment for a total of 6 weeks. Both patients were asymp-
tomatic at a follow-up arranged 4months after discharge.
Immunological laboratory screening including serum
immunoglobulin, IgG subclasses, antibody response,
immunophenotyping, DHR test and complement function
assay (CH 50) was performed to investigate any predispos-
ing immunologic deficiency. Down syndrome could be as-
sociated with humoral and cellular defects. In case 1,
lymphocyte subpopulation analysis showed a mildly re-
duced CD4+ lymphocytes (24%), with a normal absolute
value for age (av: 416 cells/μL). The immunological
screening was totally normal in the second case. Neither
patient had been previously vaccinated with the quadriva-
lent meningococcal vaccine which was subsequently of-
fered at follow-up (quadrivalent meningococcal conjugate
vaccine and 4CMenB vaccine).
Discussion and conclusions
N. meningitidis (Nm) is a well-known pathogen in men-
ingitis and sepsis, but other end-organ manifestations of
IMD such as pneumonia and septic arthritis are also de-
scribed. Meningococcal epidemiology is unpredictable
and not completely understood leading to a high variabil-
ity in the incidence of IMD [10]. RT-PCR is approximately
3-times more sensitive than culture in identifying N.
meningitidis from biological samples, therefore meningo-
coccal infections might be underdiagnosed when using
culture-based methods alone, especially in the event of an
unusual presentation such as arthritis [9, 11–15]. Menin-
gococcal arthritis is a recognized complication of menin-
gococcal infections reported in up to 7.5% of cases in
association with IMD. Nevertheless, PMA is an unusual
presentation reported in 2.6% of meningococcal infections
and has an excellent prognosis [1, 16]. According to Bara-
hona et al. [1], PMA is considered a rare entity, account-
ing for 1.5–1.8% of all pediatric cases of pyogenic arthritis
a b
Fig. 1 Most significant coxofemoral joint MRI findings performed on the third day after admission in both cases. (a). Case I: coxofemoral joint MRI
(frontal projection) showed left coxofemoral intra-articular effusion (continuous arrows) with oedematous-flogistic muscular involvement (dotted
arrow) but no bone involvement. (b). Case II: Coxofemoral joint MRI (axial projection) showed mild right hip joint effusion (continuous arrows)
and fasciitis muscular effusion (dotted arrows); no bone lesions were detected
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isolated by synovial fluid culture [17].To our knowledge,
less than 50 cases are described in the literature, combin-
ing adult and pediatric patients [1–7, 17, 18]. PMA is de-
fined as the presence of septic arthritis without meningeal
signs or meningococcaemia and the detection of N.
meningitidis in synovial fluid and/or blood analysis. The
knee is described as the most affected joint followed by
the ankle. Approximately 50% of patients were children less
than 4 years of age [18]. Despite its unusual presentation it
is important not to miss a diagnosis of meningococcal sep-
tic arthritis as appropriate treatment and prophylaxis for
contacts are required.
When facing uncommon or no specific presentations
(e.g., pneumonia, septic arthritis), clinicians are less
likely to suspect meningococcal disease and thus to sub-
mit clinical specimens for laboratory confirmation than
in classic IMD cases (meningitis or sepsis). Moreover, in
the context of an unusual presentation is more likely to
collect specimens for microbiological identification after
having started empirical antimicrobial treatment, redu-
cing the likelihood for the pathogen isolation. This sug-
gests that a proportion of laboratory diagnosis of PMA
might be lost and that disease burden PMA might be
underestimated. RT-PCR improves the diagnostic rates
after having started antibiotic treatment and also allows
the characterization of the Nm serogroups, which con-
tributes to a better understanding of the meningococcal
disease epidemiology.
A rise in the number of NmY infections has been ob-
served in the last 20 years in several countries [19, 20].
In Italy, despite an overall invariable incidence of IMD
of 0.3 cases/100,000 inhabitants since 2007, an increased
proportion of NmY has been observed [21]. Similarly, to
other European countries, serogroup B and C are re-
sponsible for the majority of cases, although the propor-
tion of NmY IMD cases has steadily increased over the
years [20], surging from 2% in 2007 to 17% in 2013, in
particular among 5- to 14-year-old patients, which is re-
ported to be the most affected group since 2008 [21].
In our laboratory, we routinely use RT-PCR tests on
blood and other normally sterile fluids – as previously
described [9] – in association with culture to enhance
the reliability of the IMD laboratory diagnosis. In the
cases we presented, even though arthrocentesis was per-
formed after having started antimicrobial therapy,
RT-PCR on synovial fluid was able to detect NmY ST23/
clusterA3, whereas the cultures resulted negative.
According to the pubMLST database, among invasive
NmY the ST-23/cluster A3 complex (cc23) is the major
cluster complex (cc) reported in Italy. The ST-23/cluster
A3 complex could account for more than 85% of Italian
IMD cases caused by NmY (http://pubmlst.org/neisseria)
and five of the total of six cases of meningococcal arth-
ritis caused by NmY are reported (from 2011 to 2018) in
Europe were characterized as ST-23/cluster A3 complex
(cc23). A limitation of this analysis is that the submis-
sion of isolates to the database is voluntary, which might
represent a selection bias and underrepresent the real
incidence rate.
In conclusion, our report aims to raise awareness among
physicians of the atypical presentations of IMD and high-
lights the diagnostic sensitivity improvements added by the
routine use of RT-PCR for IMD, also in the event of un-
usual presentations, such as PMA. Better quality in labora-
tory confirmation of IMD is necessary to improve the
understanding of the epidemiological features of Nm
disease. Currently NmY is not part of the Italian
Immunization Program for children under 11-years-old
and, based on our limited data we cannot draw conclusions
about a dedicated national vaccination strategy. However,
we believe that a more accurate surveillance based on cul-
tural and molecular methods would better frame the diffu-
sion of the different meningococcal serogroups allowing a
review of the current vaccination strategies. A better esti-
mation of IMD rates, based on active and appropriate sur-
veillance, would likely help in the development of an
effective national vaccination program, which remains the
best control strategy to prevent invasive meningococcal
disease.
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